PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
26.83%
Revenue growth 1.25-1.5x CX's 24.19%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
334.67%
Gross profit growth above 1.5x CX's 15.42%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
1494.64%
EBIT growth above 1.5x CX's 16.66%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
1494.64%
Operating income growth above 1.5x CX's 16.66%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
93.84%
Net income growth above 1.5x CX's 27.58%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
92.06%
EPS growth under 50% of CX's 1145.73%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
93.55%
Diluted EPS growth under 50% of CX's 1145.73%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.20%
Share reduction more than 1.5x CX's 1.76%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.24%
Diluted share reduction more than 1.5x CX's 1.76%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
370.57%
10Y revenue/share CAGR above 1.5x CX's 6.70%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
149.32%
5Y revenue/share CAGR similar to CX's 139.39%. Walter Schloss might see both companies benefiting from the same mid-term trends.
88.51%
3Y revenue/share CAGR at 50-75% of CX's 169.07%. Martin Whitman would question if the firm lags behind competitor innovations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
367.08%
Positive 10Y CAGR while CX is negative. John Neff might see a substantial advantage in bottom-line trajectory.
146.23%
Below 50% of CX's 3088.64%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
83.31%
3Y net income/share CAGR 75-90% of CX's 95.01%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We cut SG&A while CX invests at 14.36%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.